Literature DB >> 10596685

Do hormonal contraceptives influence asthma severity?

L Forbes1, D Jarvis, P Burney.   

Abstract

There is some evidence that endogenous progesterone and oestrogen levels influence asthma severity in females, but little is known about the effects of hormonal contraceptives. This study aimed to describe how females with asthma perceived the effects of hormonal contraceptives on symptom severity, and to describe the association between asthma severity and current use of hormonal contraceptives. A questionnaire was sent to 891 females with asthma aged 20-30 yrs recruited from general practice registers in South London, UK. It asked about perceptions of the effects of hormonal contraceptives on asthma severity, about current use of hormonal contraceptives, and included an asthma quality of life questionnaire as a measure of asthma severity. About 6% of respondents who had ever used hormonal contraceptives reported that these had influenced asthma severity, -4% reporting worsening and 2% an improvement. There were no significant differences in asthma quality of life score between females currently taking hormonal contraceptives and those not, between those taking combined and progesterone-only preparations, or between users of different progestagen types. This study found no evidence of any important effect of hormonal contraceptives or their components on asthma severity in a group of females with relatively mild asthma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10596685     DOI: 10.1183/09031936.99.14510289

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  10 in total

1.  Exogenous female sex steroid hormones and risk of asthma and asthma-like symptoms: a cross sectional study of the general population.

Authors:  P Lange; J Parner; E Prescott; C S Ulrik; J Vestbo
Journal:  Thorax       Date:  2001-08       Impact factor: 9.139

Review 2.  Sex differences and sex steroids in lung health and disease.

Authors:  Elizabeth A Townsend; Virginia M Miller; Y S Prakash
Journal:  Endocr Rev       Date:  2012-01-12       Impact factor: 19.871

3.  Sex Hormones and Lung Inflammation.

Authors:  Jorge Reyes-García; Luis M Montaño; Abril Carbajal-García; Yong-Xiao Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Factorial design for the analysis of patient's quality of life in asthma.

Authors:  Agnes Mészáros; Romána Zelkó; Andrea Meskó; Zoltán Vincze
Journal:  Qual Life Res       Date:  2005-02       Impact factor: 4.147

Review 5.  Sex steroid signaling: implications for lung diseases.

Authors:  Venkatachalem Sathish; Yvette N Martin; Y S Prakash
Journal:  Pharmacol Ther       Date:  2015-01-14       Impact factor: 12.310

Review 6.  Gender aspects and influence of hormones on bronchial asthma - Secondary publication and update.

Authors:  Iris Koper; Karin Hufnagl; Rainer Ehmann
Journal:  World Allergy Organ J       Date:  2017-12-27       Impact factor: 4.084

7.  Endogenous and exogenous sex steroid hormones in asthma and allergy in females: A systematic review and meta-analysis.

Authors:  Nicola McCleary; Bright I Nwaru; Ulugbek B Nurmatov; Hilary Critchley; Aziz Sheikh
Journal:  J Allergy Clin Immunol       Date:  2018-01-02       Impact factor: 10.793

8.  Exogenous sex steroid hormones and asthma in females: protocol for a population-based retrospective cohort study using a UK primary care database.

Authors:  Bright I Nwaru; Colin R Simpson; Ireneous N Soyiri; Rebecca Pillinger; Francis Appiagyei; Dermot Ryan; Hilary Critchley; David B Price; Catherine M Hawrylowicz; Aziz Sheikh
Journal:  BMJ Open       Date:  2018-06-27       Impact factor: 2.692

9.  Hormonal contraceptives and asthma in women of reproductive age: analysis of data from serial national Scottish Health Surveys.

Authors:  Bright I Nwaru; Aziz Sheikh
Journal:  J R Soc Med       Date:  2015-07-07       Impact factor: 5.344

10.  Endogenous and exogenous sex steroid hormones in asthma and allergy in females: protocol for a systematic review and meta-analysis.

Authors:  Bright I Nwaru; Ulugbek Nurmatov; Aziz Sheikh
Journal:  NPJ Prim Care Respir Med       Date:  2016-01-28       Impact factor: 2.871

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.